(19)
(11) EP 4 739 696 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24835525.7

(22) Date of filing: 03.07.2024
(51) International Patent Classification (IPC): 
C07F 9/6558(2006.01)
A61K 31/675(2006.01)
C07F 9/655(2006.01)
A61K 31/655(2006.01)
A61P 35/00(2006.01)
C07F 9/6561(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 35/00; C07F 9/6561; C07F 9/65586; C07F 9/65522
(86) International application number:
PCT/IB2024/056519
(87) International publication number:
WO 2025/008773 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 03.07.2023 US 202363524820 P

(71) Applicant: Lunella Biotech, Inc.
Ottawa, ON K1Z 1A1 (CA)

(72) Inventors:
  • LISANTI, Michael P.
    Greater Manchester M20 2DS (GB)
  • SOTGIA, Federica
    Greater Manchester M20 2DS (GB)
  • KANGASMETSA, Jussi
    Cambridge Cambridgeshire CB2 9BX (GB)
  • DIPISA, Filippo
    Salford Greater Manchester M5 3GH (GB)

(74) Representative: Mathys & Squire 
32 London Bridge Street The Shard
London SE1 9SG
London SE1 9SG (GB)

   


(54) MITOCHONDRIA SPECIFIC TRANSCRIPTION INHIBITOR COMPOUNDS